Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors
Where
Wuhan
Age
18 years to 65 years
People
56
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06994078
Phase 2Taking people
PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
Where
Guangzhou
Age
18 years to 75 years
People
40
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT06429696
No phaseTaking people
Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
Where
Shanghai
Age
18 years to 80 years
People
216
Run by
Shanghai Chest Hospital
See details and how to joinNCT06483295
Phase 1Taking people
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
Where
Nanjing
Age
18 years and over
People
60
Run by
Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06992583
Phase 1Taking people
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
Where
Beijing, Changchun
Age
18 years and over
People
102
Run by
Chipscreen Biosciences, Ltd.
See details and how to joinNCT06902350
Phase 2Taking people
PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC
Where
Guangzhou
Age
18 years to 75 years
People
83
Run by
Sun Yat-sen University
See details and how to joinNCT06977074
No phaseTaking people
Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
250
Run by
Shanghai Chest Hospital
See details and how to joinNCT04977791
No phaseTaking people
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
Where
Shanghai
Age
18 years and over
People
500
Run by
Shanghai Chest Hospital
See details and how to joinNCT05701787
No phaseTaking people
Association of Psychological Distress in Patients With Lung Cancer
Where
Shanghai
Age
18 years and over
People
500
Run by
Shanghai Chest Hospital
See details and how to joinNCT06218901
Phase 1/2Taking people
Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI
Where
Shanghai
Age
18 years and over
People
156
Run by
Avistone Biotechnology Co., Ltd.
See details and how to joinNCT06343064
Phase 2Taking people
Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC.
Where
Guangzhou
Age
18 years and over
People
120
Run by
Avistone Biotechnology Co., Ltd.
See details and how to joinNCT06574347
No phaseTaking people
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan
Where
Shanghai
Age
18 years to 75 years
People
200
Run by
Shanghai Chest Hospital
See details and how to joinNCT06358222
Phase 2Taking people
Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
32
Run by
Shanghai Chest Hospital
See details and how to joinNCT06659042
No phaseTaking people
The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer
Where
Changsha
Age
18 years and over
People
1,270
Run by
Second Xiangya Hospital of Central South University
See details and how to joinNCT06975384
Phase 3Taking people
Bovine Reinforcement in Stomach, Colorectal and Lung Operation
Where
Shanghai
Age
18 years to 75 years
People
172
Run by
Shanghai Cingularbio Co. Ltd
See details and how to joinNCT06968221
Phase 1Taking people
Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer
Where
Hangzhou
Age
18 years to 70 years
People
18
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06972576
Phase 1Taking people
A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors
Where
Changchuan
Age
18 years and over
People
180
Run by
CSPC Megalith Biopharmaceutical Co.,Ltd.
See details and how to joinNCT06970795
Phase 1Taking people
A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 75 years
People
122
Run by
HC Biopharma Inc.
See details and how to joinNCT06307925
Phase 1Not yet taking people in China
NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC
Where
Chengdu
Age
18 years to 75 years
People
20
Run by
Sichuan University
See details and how to joinNCT06966583
Phase 1Not yet taking people in China
A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
Where
Hangzhou, Shanghai
Age
18 years and over
People
762
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT06963502
No phaseEnrolling by invitation
Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer
Where
Shanghai
People
500
Run by
Shanghai Chest Hospital
See details and how to joinNCT06962449
Phase 3Not yet taking people in China
Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis
Where
Wuhan
Age
18 years to 85 years
People
174
Run by
Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT06961188
Phase 3Not yet taking people in China
Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase
Where
Chengdu
Age
18 years to 85 years
People
94
Run by
Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT06961201
No phaseTaking people
Organoid-guided Personalized Treatment of Pleural Effusion
Where
Zhengzhou
Age
18 years and over
People
20
Run by
Henan Cancer Hospital
See details and how to joinNCT06959173
No phaseTaking people
Multiomics Tumor Evolution Model of NSCLC
Where
Beijing
Age
18 years and over
People
300
Run by
Peking University People's Hospital
See details and how to joinNCT05352035